BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8175117)

  • 41. Long-term ranitidine treatment for the maintenance of duodenal ulcer healing.
    Lombardo L; Babando GM; De La Pierre M; Masoero G; Sategna-Guidetti C; Imarisio P; Di Napoli A
    Int J Tissue React; 1983; 5(3):323-8. PubMed ID: 6317594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranitidine: prophylaxis of duodenal ulcer recurrence.
    Lee FI; Fielding JD; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Mackay C; Mitchell KG; Pickard WR; Orchard RT
    Hepatogastroenterology; 1984 Apr; 31(2):85-7. PubMed ID: 6327479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Popiela T; Kulig J; Karcz D; Tabor J; Torres J; Márquez M; Fillat O; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
    Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chief cell mass after short-term ranitidine treatment for duodenal ulcer.
    Testino G
    Hepatogastroenterology; 1992 Aug; 39(4):358-61. PubMed ID: 1427584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Activity of lysozyme in serum and selected granulocytic cytoenzymatic markers evaluated in patients with duodenal ulcer treated with ranitidine].
    Hrycek A; Dabek J; Zielińska-Stasiura H; Kłaptocz B; Nowakowska M; Radosz-Komoniewska H
    Wiad Lek; 1994 Feb; 47(3-4):84-7. PubMed ID: 7975647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of antibiotic therapy on bleeding from duodenal ulcer.
    Sonnenberg A; Olson CA; Zhang J
    Am J Gastroenterol; 1999 Apr; 94(4):950-4. PubMed ID: 10201462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind randomized, multicenter study comparing aluminium phosphate gel with rantitidine in the short-term treatment of duodenal ulcer.
    Parente F; Bianchi Porro G; Canali A; Bensi G
    Hepatogastroenterology; 1995 Apr; 42(2):95-9. PubMed ID: 7672773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse].
    Bado A; Corrion F; Bernades P; Chevalier T; Galmiche JP; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F
    Gastroenterol Clin Biol; 1994; 18(6-7):623-9. PubMed ID: 7875420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher doses of ranitidine in the acute treatment of duodenal ulcer.
    Dekkers CP; Forssell H; Hegarty J; Määttänen J; Toftgaard CL; Waldum HL; Naessens H; Van Wilder P
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):485. PubMed ID: 7614113
    [No Abstract]   [Full Text] [Related]  

  • 53. Duodenal ulcer in the Sudan. Clinical features and treatment with H2 blockers.
    Ahmed M el-B ; Arbab BM; Homeida MM
    Trop Geogr Med; 1993; 45(6):287-9. PubMed ID: 8116060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Duodenal ulcer - multicenter double-blind study with proglumide].
    Bergemann W; Consentius K; Braun HE; Hirschmann H; Marowski B; Munck A; Rehs HU; Stopik D; Wilke G
    Med Klin; 1981 Apr; 76(8):226-9. PubMed ID: 7231338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of peptic ulcer with i.v. ranitidine. A treatment possibility in special cases. Experiences from general practice].
    Kemmer R; Taenzer HJ
    Fortschr Med; 1984 Feb; 102(8):201-2. PubMed ID: 6086476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Etintidine versus ranitidine: a single evening dose in the treatment of duodenal ulcer].
    Dammann HG; Walter TA; Müller P; Simon B
    Dtsch Med Wochenschr; 1984 Jun; 109(22):886-7. PubMed ID: 6327220
    [No Abstract]   [Full Text] [Related]  

  • 57. Short report: effect of ranitidine on duodenal ulcer healing in patients with cirrhosis of the liver.
    Ljubicic W; Bilić A; Roić D
    Aliment Pharmacol Ther; 1993 Apr; 7(2):233-5. PubMed ID: 8485276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Luminal bicarbonate outflow in chronic antral erosions is suppressed by pirenzepine.
    Guslandi M; Masci E; Ballarin E; Imbimbo BP; Daniotti S
    Hepatogastroenterology; 1987 Aug; 34(4):171-3. PubMed ID: 3666666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Personal experience in the treatment of duodenal ulcer with ranitidine].
    Civello IM; De Giovanni L; Marcovits de Spizza F; Destito C; Barone Adesi TL; Wiel Marin A
    Clin Ter; 1983 Sep; 106(5):357-9. PubMed ID: 6315294
    [No Abstract]   [Full Text] [Related]  

  • 60. [High dose aluminum hydroxide in the treatment of duodenal ulcer. Controlled clinical study versus ranitidine].
    Galeone M; Moise G; Toti GL; Cacioli D; Megevand J
    Clin Ter; 1983 Jul; 106(2):117-20. PubMed ID: 6313279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.